# OnCo record perseus (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/perseus/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "perseus", "NCT03710603" ;
  schema:name "PERSEUS"@en ;
  schema:description "Adding daratumumab to the standard three-drug induction and to maintenance cut the risk of progression by more than half in transplant-eligible myeloma."@en ;
  schema:url <https://onco.cc/trials/perseus/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03710603>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2312054> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-12-14" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-transplant-eligible/> ;
  onco:technologies <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:drugs <https://onco.cc/drugs/daratumumab/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:terms <https://onco.cc/terms/mrd-negativity-myeloma/> ;
  onco:people <https://onco.cc/people/pieter-sonneveld/> .